Company: IPGP
Filing Date: 2025-04-07
Form Type: DEF 14A
Source: 0001111928-25-000054
Chunk: 58

Company: IPG PHOTONICS CORP
Filing Date: 2025-04-07
Form: DEF 14A
Chunk 58
---
             |     |               | — |                 |                                 | — |         |     |              | — |                 |                                | — |           |
| Timothy Mammen         |     |               |   |               — |                                 |   |       — |     |              |   |           7,087 |                                |   |   621,317 |
| Trevor Ness            |     |               |   |               — |                                 |   |       — |     |              |   |           5,774 |                                |   |   506,207 |
| Angelo Lopresti        |     |               |   |               — |                                 |   |       — |     |              |   |           5,874 |                                |   |   514,974 |
| Igor Samartsev         |     |               |   |               — |                                 |   |       — |     |              |   |           2,333 |                                |   |   204,534 |
| Eugene Scherbakov      |     |               |   |          13,000 |                                 |   | 202,636 |     |              |   |          19,729 |                                |   | 1,735,005 |
| Alexander Ovtchinnikov |     |               |   |               — |                                 |   |       — |     |              |   |           5,820 |                                |   |   510,239 |

(1) The value realized is based on the difference between the reported closing common stock price on the date of exercise and the exercise price of the stock option; the dollar amount represents the pre-tax value received on exercise.

(2) The value realized is based on the closing common stock prices on the vesting dates of service-based RSUs and PSUs; the dollar amount represents the pre-tax value received on vesting.

Post-Employment Compensation and Other Employment Agreements

The Company has entered into employment agreements with each of the NEOs, effective through December 31, 2024 (or December 31, 2025 for Dr. Gitin) and was party to employment agreements with Drs. Scherbakov and Ovtchinnikov during their employment. Upon expiration, the currently effective employment agreements automatically renew for successive one-year periods, unless the Company or a NEO provides written notice of non-renewal at least six months prior to the end of the then-current term. In the event